UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
2004, Palliative care consultations, ISBN 9780198528074
eBook
2005, Clinics in developmental medicine, ISBN 9781898683384, Volume no. 166, ix, 359
Book
The New England journal of medicine, ISSN 0028-4793, 08/2017, Volume 377, Issue 9, pp. 829 - 838
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Lung Neoplasms - drug therapy | Pyrazoles - therapeutic use | Follow-Up Studies | Lung Neoplasms - mortality | Humans | Middle Aged | Male | Antineoplastic Agents - therapeutic use | Protein Kinase Inhibitors - adverse effects | Central Nervous System Neoplasms - secondary | Young Adult | Pyridines - adverse effects | Anaplastic Lymphoma Kinase | Antineoplastic Agents - adverse effects | Aged, 80 and over | Receptor Protein-Tyrosine Kinases - antagonists & inhibitors | Adult | Female | Receptor Protein-Tyrosine Kinases - analysis | Pyrazoles - adverse effects | Pyridines - therapeutic use | Crizotinib | Carbazoles - adverse effects | Kaplan-Meier Estimate | Carcinoma, Non-Small-Cell Lung - mortality | Disease-Free Survival | Animals | Piperidines - therapeutic use | Protein Kinase Inhibitors - therapeutic use | Piperidines - adverse effects | Intention to Treat Analysis | Carbazoles - therapeutic use | Carcinoma, Non-Small-Cell Lung - drug therapy | Central Nervous System Neoplasms - drug therapy | Drugs | Care and treatment | Analysis | Comparative analysis | Lung cancer, Non-small cell | Health aspects | Systemic diseases | Toxicity | Lung cancer | Central nervous system | Non-small cell lung carcinoma | Oncology | Nervous system | Metastasis | Radiation therapy | Patients | Lymphoma | Cancer therapies | Survival | Mutation | Protein-tyrosine kinase | Drug dosages | Tumors | Index Medicus | Abridged Index Medicus
Journal Article
The Journal of pathology, ISSN 0022-3417, 01/2014, Volume 232, Issue 1, pp. 23 - 31
treatment | breast cancer | pathology | intratumour heterogeneity | metastasis | autopsy | Pathology | Oncology | Life Sciences & Biomedicine | Science & Technology | Bone Neoplasms - mortality | Age Factors | Oligonucleotide Array Sequence Analysis | Lung Neoplasms - mortality | Humans | Middle Aged | Gene Expression Regulation, Neoplastic | Bone Neoplasms - secondary | Gene Expression Profiling | Liver Neoplasms - mortality | Central Nervous System Neoplasms - secondary | DNA Copy Number Variations | Lung Neoplasms - secondary | Autopsy | Biomarkers, Tumor - metabolism | Female | Bone Neoplasms - genetics | Retrospective Studies | Liver Neoplasms - secondary | Genital Neoplasms, Female - genetics | Lung Neoplasms - genetics | Liver Neoplasms - genetics | Central Nervous System Neoplasms - genetics | Lymphatic Metastasis | Queensland - epidemiology | Disease Progression | Genital Neoplasms, Female - mortality | Breast Neoplasms - genetics | Comparative Genomic Hybridization | Breast Neoplasms - pathology | Genital Neoplasms, Female - secondary | Breast Neoplasms - mortality | Central Nervous System Neoplasms - mortality | Cohort Studies | Index Medicus | Original Papers
Journal Article
European journal of cancer (1990), ISSN 0959-8049, 04/2018, Volume 93, pp. 57 - 68
Diffuse large B-Cell lymphoma | Rituximab | Autologous stem cell transplant | Secondary CNS | Central nervous system | Life Sciences & Biomedicine | Oncology | Science & Technology | Prognosis | Follow-Up Studies | Humans | Middle Aged | Neoplasm Recurrence, Local - drug therapy | Male | Neoplasms, Second Primary - mortality | Neoplasm Recurrence, Local - mortality | Neoplasm Recurrence, Local - pathology | Young Adult | Aged, 80 and over | Adult | Female | Retrospective Studies | Lymphoma, Large B-Cell, Diffuse - drug therapy | Lymphoma, Large B-Cell, Diffuse - pathology | Survival Rate | Lymphoma, Large B-Cell, Diffuse - mortality | Central Nervous System Neoplasms - pathology | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Aged | Neoplasms, Second Primary - drug therapy | Central Nervous System Neoplasms - drug therapy | Neoplasms, Second Primary - pathology | Central Nervous System Neoplasms - mortality | Care and treatment | Lymphomas | Patient outcomes | Analysis | Autografts | Stem cell transplantation | Medical records | Nervous system | Transplantation | Multivariate analysis | Patients | Lymphoma | Chemotherapy | Lymphocytes B | Platinum | Medical prognosis | Stem cells | Methotrexate | B-cell lymphoma | Index Medicus | autologous stem cell transplant | secondary CNS | rituximab | Diffuse large B-cell lymphoma | central nervous system
Journal Article
Clinical cancer research, ISSN 1078-0432, 12/2010, Volume 16, Issue 23, pp. 5873 - 5882
Life Sciences & Biomedicine | Oncology | Science & Technology | Tumors of the respiratory system and mediastinum | Biological and medical sciences | Medical sciences | Antineoplastic agents | Pharmacology. Drug treatments | Pneumology | Erlotinib Hydrochloride | Lung Neoplasms - drug therapy | Lung Neoplasms - mortality | Humans | Middle Aged | Lung Neoplasms - pathology | Male | Antineoplastic Agents - therapeutic use | Genes, erbB-1 - physiology | Central Nervous System Neoplasms - secondary | Mutation - physiology | Antineoplastic Agents - adverse effects | Adult | Female | Carcinoma, Non-Small-Cell Lung - pathology | Lung Neoplasms - genetics | Carcinoma, Non-Small-Cell Lung - genetics | Central Nervous System Neoplasms - genetics | Genotype | Treatment Outcome | Carcinoma, Non-Small-Cell Lung - mortality | Disease Progression | Randomized Controlled Trials as Topic | Quinazolines - therapeutic use | Quinazolines - adverse effects | Survival Analysis | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | Neoplasm Staging | Central Nervous System Neoplasms - diagnosis | Central Nervous System Neoplasms - mortality | Index Medicus | non-small cell lung cancer | secondary meningeal neoplasms | Secondary brain neoplasms | incidence | epidermal growth factor receptor tyrosine kinase inhibitors
Journal Article
Clinical cancer research, ISSN 1078-0432, 07/2011, Volume 17, Issue 14, pp. 4834 - 4843
Life Sciences & Biomedicine | Oncology | Science & Technology | Gynecology. Andrology. Obstetrics | Mammary gland diseases | Pharmacology. Drug treatments | Biological and medical sciences | Medical sciences | Antineoplastic agents | Tumors | Receptor, ErbB-2 - genetics | Humans | Middle Aged | Kaplan-Meier Estimate | Receptor, ErbB-2 - metabolism | Central Nervous System Neoplasms - therapy | Central Nervous System Neoplasms - epidemiology | Molecular Targeted Therapy | Disease Progression | Central Nervous System Neoplasms - secondary | Incidence | Breast Neoplasms - therapy | Time Factors | Breast Neoplasms - pathology | Adult | Breast Neoplasms - mortality | Female | Registries | Aged | Receptor, ErbB-2 - antagonists & inhibitors | Neoplasm Staging | Central Nervous System Neoplasms - mortality | Breast Neoplasms - epidemiology | trastuzumab | Chemotherapy | Statistical analysis | Surgery | Central nervous system | Breast cancer | Hormones | Radiotherapy | Statistics | Survival | Metastases | Index Medicus
Journal Article
International journal of gynecological cancer, ISSN 1048-891X, 09/2015, Volume 25, Issue 7, pp. 1232 - 1238
Hereditary breast and ovarian cancer | Central nervous system metastasis | Ovarian cancer | Oncology | Life Sciences & Biomedicine | Obstetrics & Gynecology | Science & Technology | Genetic Testing | Prognosis | Follow-Up Studies | Adenocarcinoma, Mucinous - pathology | Endometrial Neoplasms - mortality | Adenocarcinoma, Clear Cell - mortality | Humans | Middle Aged | Spinal Cord Neoplasms - secondary | Ovarian Neoplasms - pathology | Cystadenocarcinoma, Serous - genetics | Ovarian Neoplasms - mortality | Cystadenocarcinoma, Serous - pathology | Ovarian Neoplasms - genetics | Brain Neoplasms - secondary | Endometrial Neoplasms - genetics | Cystadenocarcinoma, Serous - therapy | Adult | Female | Brain Neoplasms - mortality | Adenocarcinoma, Mucinous - therapy | Spinal Cord Neoplasms - genetics | Spinal Cord Neoplasms - therapy | Genetic Predisposition to Disease | Neoplasm Invasiveness | Brain Neoplasms - genetics | Survival Rate | Lymphatic Metastasis | Mutation - genetics | Adenocarcinoma, Mucinous - mortality | Spinal Cord Neoplasms - mortality | Adenocarcinoma, Clear Cell - therapy | Brain Neoplasms - therapy | Cystadenocarcinoma, Serous - mortality | Endometrial Neoplasms - therapy | Ovarian Neoplasms - therapy | Endometrial Neoplasms - pathology | Adenocarcinoma, Clear Cell - pathology | Aged | Adenocarcinoma, Mucinous - genetics | Neoplasm Staging | Adenocarcinoma, Clear Cell - genetics | Index Medicus
Journal Article
Nature communications, ISSN 2041-1723, 11/2015, Volume 6, Issue 1, pp. 8839 - 8839
Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Meningeal Neoplasms - genetics | Genomics | Humans | Glioblastoma - blood | Glioblastoma - cerebrospinal fluid | Brain Neoplasms - genetics | Lung Neoplasms - pathology | Medulloblastoma - blood | Brain Neoplasms - secondary | Meningeal Neoplasms - cerebrospinal fluid | DNA, Neoplasm - blood | Glioblastoma - genetics | Breast Neoplasms - pathology | Female | Medulloblastoma - genetics | Meningeal Neoplasms - blood | Gene Expression Regulation, Neoplastic - physiology | DNA, Neoplasm - cerebrospinal fluid | Medulloblastoma - cerebrospinal fluid | Brain | Alterations | Brain tumors | Brain cancer | Central nervous system | Biomarkers | Meninges | Cerebrospinal fluid | Mutation | Deoxyribonucleic acid--DNA | Tumors | Cancer | Index Medicus
Journal Article
World neurosurgery, ISSN 1878-8750, 2014, Volume 81, Issue 3, pp. 594 - 599
Neurosurgery | Stereotactic radiosurgery | Secondary neoplasm | Late complications | Dedifferentiation | Malignant transformation | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Surgery | Science & Technology | Humans | Neoplasms, Radiation-Induced - etiology | Risk Factors | Neuroma, Acoustic - surgery | Central Nervous System Neoplasms - surgery | Radiosurgery - statistics & numerical data | Central Nervous System Neoplasms - epidemiology | Neoplasms, Radiation-Induced - epidemiology | Neuroma, Acoustic - epidemiology | Radiosurgery - adverse effects | Neoplasms, Second Primary - epidemiology | Neoplasms, Second Primary - etiology | Nervous system diseases | Nuclear radiation | Radiosurgery | Tumors | Index Medicus
Journal Article
Annals of surgical oncology, ISSN 1068-9265, 12/2016, Volume 23, Issue S5, pp. 946 - 953
Oncology | Medicine & Public Health | Surgical Oncology | Surgery | Life Sciences & Biomedicine | Science & Technology | Adenoma - ethnology | Tibet - ethnology | Age Factors | Adenoma - epidemiology | Humans | Middle Aged | Spinal Cord Neoplasms - secondary | Brain Neoplasms - pathology | Child, Preschool | Infant | Male | Incidence | Young Adult | Brain Neoplasms - secondary | Meningioma - epidemiology | Nerve Sheath Neoplasms - pathology | Adult | Female | Meningioma - ethnology | Child | Glioblastoma - ethnology | Infant, Newborn | Spinal Cord Neoplasms - ethnology | Pituitary Neoplasms - epidemiology | Nerve Sheath Neoplasms - epidemiology | Pituitary Neoplasms - pathology | China - epidemiology | Glioblastoma - epidemiology | Meningioma - pathology | Glioblastoma - pathology | Adolescent | Sex Factors | Adenoma - pathology | Brain - pathology | Spinal Cord Neoplasms - pathology | Nerve Sheath Neoplasms - ethnology | Brain Neoplasms - epidemiology | Brain Neoplasms - ethnology | Spinal Cord Neoplasms - epidemiology | Gliomas | Analysis | Brain tumors | Central nervous system | Cancer | Index Medicus
Journal Article